google-site-verification: googlec7193c3de77668c9.html

Pooled analysis reveals semaglutide shows good efficacy in older adults aged over 65 years

[
A new analysis of the STEP trials carried out by semaglutide manufacturer Novo Nordisk has analyzed various trials to show the safety and efficacy of the obesity drug semaglutide in older adults (over 65 years), and found similar efficacy and safety as in the general trial populations. The study is by Prof Luca Busetto from the University of Padova in Italy and colleagues, including those from Novo Nordisk.


Source link

Advertisements
Views: 0

See also  Stanford psychologist behind the controversial "Stanford Prison Experiment" dies at 91

Check Also

Cutting calories by 10% to 15% may boost healthy aging without extreme diets

[ Credit: CC0 Public Domain Search the web, and you’ll find any number of biohacking …

Health advice is all over social media. Here's how to vet claims

[ Health and wellness advice is available in abundance on social media—from trendy to informative …

Everyone on hantavirus-hit ship 'high-risk contact', must be monitored: WHO

[ The World Health Organization said Saturday it considered everyone on board a cruise ship …

Leave a Reply

Available for Amazon Prime